Education

The Montgomery County school board approved design plans for Crown High School (9410 Fields Road, Gaithersburg) at its meeting this past Thursday, March 24. Crown will accommodate over 2,000 students and will alleviate the overcrowding that is occurring in nearby Gaithersburg, Northwest, Quince Orchard, Richard Montgomery, and Wootton high schools. The project is estimated to cost around $180 million.

According to the presentation, the school will utilize onsite renewable energy sources such as solar panels and geothermal energy. The City was able to secure the site as part of the negotiations related to the Crown Farm Annexation Agreement X-182 on August 7, 2006.  The undeveloped 30 acre site is adjacent to Crown Neighborhood Three and is located at the intersection of Fields Road and Omega Drive.


Montgomery Village

Ayres, Dyer and Rabil elected to 2022 MVF Board of Directors

Three candidates for the Montgomery Village Foundation (MVF) Board of Directors were elected to fill the three ending term seats on the Board. After about eight weeks of campaigning, meet and greet events and online candidate interviews, the results have been tallied.


Maryland

Per the State of Maryland:

ANNAPOLIS, MD—Governor Larry Hogan today announced that he has submitted a $2.8 billion supplemental budget to the General Assembly that makes key investments in some of his administration’s core priorities, including support for police and public safety, an expanded cyber readiness and workforce initiative, and critical infrastructure and public health investments. This supplemental budget also funds top priorities for county leaders and local governments.


Glenmont

Tacos Don Perez at 12321 Georgia Avenue in the Glenmont Shopping Center is currently in the final four of DC101’s Taco Tournament to determine the best tacos in the DMV.

Tacos Don Perez started off as a small, family-run catering business back in 2017. It continued that way until may 2020, when it became a once-a-week home-based pop-up when the family was left without work due to Covid-19.


Gaithersburg

GAITHERSBURG, Md., March 25, 2022/PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that NVX-CoV2373, its protein-based COVID-19 vaccine, is included in two trials now underway to evaluate its vaccine’s safety, immunogenicity, and reactogenicity as a booster amidst the ongoing COVID-19 pandemic. Both studies have initiated participant enrollment and will help to extend knowledge of how a range of vaccines, including Novavax’ COVID-19 vaccine, can be used as boosters following primary immunization.

“Additional COVID-19 booster studies are important to support vaccine choice for individuals, healthcare providers, and public health authorities,” said Filip Dubovsky, M.D., Chief Medical Officer, Novavax. “Our COVID-19 vaccine has already been recommended by multiple national policy bodies for both primary vaccination and booster settings in individuals 18 years of age and older. We look forward to adding to this body of evidence to support the expanded use of our protein-based vaccine.”


View More Stories